Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease

Olichney, J. M.; Morris, S. K.; Ochoa, C.; Salmon, D. P.; Thal, L. J.; Kutas, M.; Iragui, V. J.
October 2002
Journal of Neurology, Neurosurgery & Psychiatry;Oct2002, p377
Academic Journal
No abstract available.


Related Articles

  • A century of cognitive decline? Yankner, Bruce A. // Nature;3/9/2000, Vol. 404 Issue 6774, p125 

    Discusses cognitive decline and its relation to Alzheimer's disease and ageing. Link between longevity and cognitive decline; Amyloid deposition in Alzheimer's disease; Mild cognitive impairment in the elderly; Abnormal accumulation of aggregated proteins in frontotemporal dementia.

  • Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome. Olichney, John M.; Chan, Shiaohui; Wong, Ling M.; Schneider, Andrea; Seritan, Andreea; Niese, Adam; Jin-Chen Yang; Laird, Kelsey; Teichholtz, Sara; Khan, Sara; Tassone, Flora; Hagerman, Randi // Brain: A Journal of Neurology;May2010, Vol. 133 Issue 5, p1438 

    Fragile X-associated tremor/ataxia syndrome, a neurodegenerative disorder associated with premutation alleles (55–200 CGG repeats) of the FMR1 gene, affects many carriers in late-life. Patients with fragile X-associated tremor/ataxia syndrome typically have cerebellar ataxia, intranuclear...

  • A data-driven model of biomarker changes in sporadic Alzheimer's disease. Young, Alexandra L.; Oxtoby, Neil P.; Daga, Pankaj; Cash, David M.; Fox, Nick C.; Ourselin, Sebastien; Schott, Jonathan M.; Alexander, Daniel C. // Brain: A Journal of Neurology;Sep2014, Vol. 137 Issue 9, p2564 

    Young et al. reformulate an event-based model for the progression of Alzheimer's disease to make it applicable to a heterogeneous sporadic disease population. The enhanced model predicts the ordering of biomarker abnormality in sporadic Alzheimer's disease independently of clinical diagnoses or...

  • Similar Verbal Fluency Patterns in Amnestic Mild Cognitive Impairment and Alzheimer's Disease. Teng, Edmond; Leone-Friedman, Judith; Lee, Grace J.; Woo, Stephanie; Apostolova, Liana G.; Harrell, Shelly; Ringman, John M.; Lu, Po H. // Archives of Clinical Neuropsychology;Aug2013, Vol. 28 Issue 5, p400 

    Disproportionately greater deficits in semantic relative to phonemic verbal fluency are seen in Alzheimer's disease (AD) and have been attributed to neurodegenerative changes in the temporal lobe. Amnestic (AMN) mild cognitive impairment (MCI), which often represents incipient AD, is also...

  • Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease. Lim, Yen Ying; Maruff, Paul; Pietrzak, Robert H.; Ames, David; Ellis, Kathryn A.; Harrington, Karra; Lautenschlager, Nicola T.; Szoeke, Cassandra; Martins, Ralph N.; Masters, Colin L.; Villemagne, Victor L.; Rowe, Christopher C. // Brain: A Journal of Neurology;Jan2014, Vol. 137 Issue 1, p221 

    High amyloid has been associated with substantial episodic memory decline over 18 and 36 months in healthy older adults and individuals with mild cognitive impairment. However, the nature and magnitude of amyloid-related memory and non-memory change from the preclinical to the clinical stages of...

  • Caution needed with cognitive enhancers. Newman, Elizabeth // McKnight's Long-Term Care News;Nov2013, Vol. 34 Issue 11, p6 

    The article discusses a study related to cognitive enhancers such as rivastigmine and galantamine for treatment of Alzheimer's disease performed by researchers Andrea Tricco and Sharon Straus which do not support cognitive enhancers use for patients with mild cognitive impairment.

  • Are Guidelines Needed for the Diagnosis and Management of Incipient Alzheimer's Disease and Mild Cognitive Impairment? Palmer, Katie; Musicco, Massimo; Caltagirone, Carlo // International Journal of Alzheimer's Disease;2010, Vol. 2010, p1 

    Current research is aiming to push the boundaries of the point at which a diagnosis of Alzheimer Disease (AD) can be made. Clinical syndromes such as Mild Cognitive Impairment (MCI) and various clinical and biological markers of AD may help to identify people in the early stage of AD, before a...

  • False recognition in a mouse model of Alzheimer’s disease: rescue with sensory restriction and memantine. Romberg, Carola; McTighe, Stephanie M.; Heath, Christopher J.; Whitcomb, Daniel J.; Cho, Kwangwook; Bussey, Timothy J.; Saksida, Lisa M. // Brain: A Journal of Neurology;Jul2012, Vol. 135 Issue 7, p2103 

    Alzheimer’s disease is commonly regarded as a loss of memory for past events. However, patients with Alzheimer’s disease seem not only to forget events but also to express false confidence in remembering events that have never happened. How and why false recognition occurs in such...

  • FURTHER READING.  // PharmaWatch: CNS;Jul2009, Vol. 8 Issue 7, p33 

    The article lists the latest reports related to pharmaceutical developments including "Forecast Insight: Fibromyalgia - Regulatory caution threatens EU market expansion," "Pipeline Insight: Mild Cognitive Impairment - Unlocking the potential of prodromal Alzheimer's disease and beyond," and the...

  • Electrophysiological biomarkers for improved etiological diagnosis of cognitive impairment. Takao Yamasaki; Shozo Tobimatsu // Current Biomarker Findings;2014, Vol. 4, p69 

    Alzheimer's disease (AD), Lewy body disease (LBD), and frontotemporal lobar degeneration (FTLD) are three major types of neurodegenerative dementia. Intervention and treatment differ significantly among these major dementias, necessitating early and accurate diagnosis. Patients with AD, LBD, and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics